Cargando…

Hospitalization for acute heart failure during non‐working hours impacts on long‐term mortality: the REPORT‐HF registry

AIMS: Hospital admission during nighttime and off hours may affect the outcome of patients with various cardiovascular conditions due to suboptimal resources and personnel availability, but data for acute heart failure remain controversial. Therefore, we studied outcomes of acute heart failure patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsanos, Spyridon, Ouwerkerk, Wouter, Farmakis, Dimitrios, Collins, Sean P., Angermann, Christiane E., Dickstein, Kenneth, Tomp, Jasper, Ertl, Georg, Cleland, John, Dahlström, Ulf, Obergfell, Achim, Ghadanfar, Mathieu, Perrone, Sergio V., Hassanein, Mahmoud, Stamoulis, Konstantinos, Parissis, John, Lam, Carolyn, Filippatos, Gerasimos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567635/ https://www.ncbi.nlm.nih.gov/pubmed/37649316 http://dx.doi.org/10.1002/ehf2.14506

Ejemplares similares

Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF
por: Ouwerkerk, Wouter, et al.
Publicado: (2022)

Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice
por: Filippatos, Gerasimos, et al.
Publicado: (2015)

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry
por: Filippatos, Gerasimos, et al.
Publicado: (2015)

Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2013)

Cancer and Takotsubo syndrome: from rarity to clinical practice
por: Keramida, Kalliopi, et al.
Publicado: (2021)

Genetic Predisposition to Cardiovascular Disease in Patients With Cancer: A Clinical Perspective
por: Farmakis, Dimitrios, et al.
Publicado: (2023)

The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study
por: Ponikowski, Piotr, et al.
Publicado: (2015)

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
por: Comin-Colet, Josep, et al.
Publicado: (2013)

Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
por: Tschöpe, Carsten, et al.
Publicado: (2020)

Differential effects of inotropes and inodilators on renal function in acute cardiac care
por: Zima, Endre, et al.
Publicado: (2020)

Rationale and design of Ferinject(®) Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
por: Anker, Stefan D., et al.
Publicado: (2009)

Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy
por: Okonko, Darlington O., et al.
Publicado: (2019)

Global Longitudinal Strain of the Systemic Ventricle Is Correlated with Plasma Galectin-3 and Predicts Major Cardiovascular Events in Adult Patients with Congenital Heart Disease
por: Frogoudaki, Alexandra A., et al.
Publicado: (2020)

The COVID-19 pandemic and heart failure: lessons from GUIDE-HF( )
por: Cowie, Martin R, et al.
Publicado: (2022)

Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction
por: Woolley, Rebecca J., et al.
Publicado: (2021)

Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure
por: Kobayashi, Masatake, et al.
Publicado: (2021)

Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry
por: Tromp, Jasper, et al.
Publicado: (2018)

Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM‐HF, INOVATE‐HF, and NECTAR‐HF
por: Anand, Inder S., et al.
Publicado: (2020)

Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial
por: Störk, Stefan, et al.
Publicado: (2022)

Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo‐controlled multicentre trial
por: Cooper, Trond J., et al.
Publicado: (2022)

Prevalence and Prognostic Significance of Frailty in Asian Patients With Heart Failure: Insights From ASIAN-HF
por: Aung, Than, et al.
Publicado: (2021)

Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry
por: Tromp, Jasper, et al.
Publicado: (2018)

Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional Analysis
por: Vijay, Aishwarya, et al.
Publicado: (2023)

HEllenic Registry on Myocarditis SyndromES on behalf of Hellenic Heart Failure Association: The HERMES‐HF Registry
por: Adamopoulos, Stamatis, et al.
Publicado: (2020)

Impact of adherence to guideline‐directed therapy on risk of death in HF patients across an ejection fraction spectrum
por: Chen, Xiaojing, et al.
Publicado: (2023)

Cautivos de dios : los cazadores-recolectores de Baja California durante el período colonial
por: Rodríguez Tomp, Rosa Elba
Publicado: (2002)

Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
por: Mordi, Ify R., et al.
Publicado: (2019)

Heart failure guidelines implementation: Lifting barriers using registries and networks
por: Keramida, Kalliopi, et al.
Publicado: (2020)

Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials
por: Teerlink, John R., et al.
Publicado: (2020)

A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
por: Papageorgiou, Vasiliki, et al.
Publicado: (2021)

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial
por: Wikstrom, Gerhard, et al.
Publicado: (2009)

Impaired High‐Density Lipoprotein Function in Patients With Heart Failure
por: Emmens, Johanna E., et al.
Publicado: (2021)

Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

STOP-HF: Expanding the role of HF programs into the community
por: ElMaghawry, Mohamed, et al.
Publicado: (2014)

Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
por: Fu, Michael, et al.
Publicado: (2022)

Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT‐CHF
por: Pagnesi, Matteo, et al.
Publicado: (2021)

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2014)

Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis
por: Woehrle, Holger, et al.
Publicado: (2017)

HF GFlash
por: Rahmat, Rahmat, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_db87d3ffiv25ss55ofgpt3t2a2